Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132570) titled 'Effects of Rocuronium on Neuromuscular Blockade in Elderly Patients with Sarcopenia' on Sept. 15.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Affiliated Hospital of Yangzhou University
Condition:
Sarcopenia
Intervention:
Non-sarcopenic group:A bolus dose of rocuronium 0.6 mg/kg (2xED95) was given via intravenous injection.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Non-sarcopenic group:28;Sarcopenic group:28;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj...